Frailty
Cross-source consensus on Frailty from 2 sources and 10 claims.
2 sources · 10 claims
Uses
How it works
Risks & contraindications
Other
Other
Highlighted claims
- The frailty index was defined as the fraction of damaged health-network nodes. — Modelling lifespan reduction in an exogenous damage model of generic disease
- The study classified participants as frail if they met three frailty criteria and as prefrail if they met one or two criteria. — Healthcare utilisation patterns among frail individuals aged 50+ years: results from the Lolland-Falster Population Study (LOFUS)
- Frailty is characterized by impaired homeostatic mechanisms and reduced physiological reserve. — Healthcare utilisation patterns among frail individuals aged 50+ years: results from the Lolland-Falster Population Study (LOFUS)
- The phenomenological model represented baseline frailty as an exponentially increasing function of age. — Modelling lifespan reduction in an exogenous damage model of generic disease
- The phenomenological model assumed mortality depends only on frailty. — Modelling lifespan reduction in an exogenous damage model of generic disease
- Frailty can make minor stressors cause major clinical deterioration because multiple organ systems have limited reserve capacity. — Healthcare utilisation patterns among frail individuals aged 50+ years: results from the Lolland-Falster Population Study (LOFUS)
- Frailty is associated with falls, infections, increased morbidity and mortality, hospitalization, and institutionalization. — Healthcare utilisation patterns among frail individuals aged 50+ years: results from the Lolland-Falster Population Study (LOFUS)
- Frailty prevalence among community-dwelling older adults is generally estimated at 7-10% and rises above 25% among people older than 85 years. — Healthcare utilisation patterns among frail individuals aged 50+ years: results from the Lolland-Falster Population Study (LOFUS)
- Residual damage after disease can be estimated using post-recovery frailty or other broad health measures when long follow-up is not practical. — Modelling lifespan reduction in an exogenous damage model of generic disease
- Mental and cognitive deficits may be useful follow-up measures because they are components of frailty and are relatively easy to measure. — Modelling lifespan reduction in an exogenous damage model of generic disease